Sinphar Pharmaceutical Co (TPE:1734) E10: NT$0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1734 Sinphar Pharmaceutical Co Ltd TPE:1734
81 GF Score
Price NT$31.80
GF Value NT$31.46
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Sinphar Pharmaceutical Co E10?

Sinphar Pharmaceutical Co TPE:1734 +0.32% 81 E10 is NT$0.00 as of Mar. 2026. GuruFocus rates TPE:1734 with a GF Score™ of 81/100 and a GF Value™ of NT$31.46 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was NT$0.368. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sinphar Pharmaceutical Co's average E10 Growth Rate was 30.40% per year. During the past 3 years, the average E10 Growth Rate was 16.80% per year. During the past 5 years, the average E10 Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sinphar Pharmaceutical Co was 16.80% per year. The lowest was -4.40% per year. And the median was 5.85% per year.

As of today (2026-08-08), Sinphar Pharmaceutical Co's current stock price is NT$31.80. Sinphar Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was NT$0.00. Sinphar Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Sinphar Pharmaceutical Co was 122.94. The lowest was 26.00. And the median was 61.52.


Sinphar Pharmaceutical Co  (TPE:1734) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Sinphar Pharmaceutical Co was 122.94. The lowest was 26.00. And the median was 61.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sinphar Pharmaceutical Co E10 Related Terms


Sinphar Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Sinphar Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinphar Pharmaceutical Co E10 Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.42 0.42 0.48 0.67

Sinphar Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.61 0.66 0.67 0.00

TPE:1734 vs VRTX, REGN, RVMD: E10 Comparison

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Shiller PE Ratio falls into.


TPE:1734
81GF Score
Sinphar Pharmaceutical Co Ltd TPE:1734
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinphar Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.368/330.2130*330.2130
=0.368

Current CPI (Mar. 2026) = 330.2130.

Sinphar Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 -0.008 241.018 -0.011
201609 -0.033 241.428 -0.045
201612 0.207 241.432 0.283
201703 -0.042 243.801 -0.057
201706 0.050 244.955 0.067
201709 0.067 246.819 0.090
201712 0.108 246.524 0.145
201803 0.083 249.554 0.110
201806 -0.008 251.989 -0.010
201809 -0.075 252.439 -0.098
201812 0.033 251.233 0.043
201903 0.075 254.202 0.097
201906 -0.125 256.143 -0.161
201909 -0.050 256.759 -0.064
201912 0.166 256.974 0.213
202003 0.133 258.115 0.170
202006 0.042 257.797 0.054
202009 -0.050 260.280 -0.063
202012 -0.266 260.474 -0.337
202103 0.025 264.877 0.031
202106 0.025 271.696 0.030
202109 -0.166 274.310 -0.200
202112 -0.075 278.802 -0.089
202203 0.291 287.504 0.334
202206 0.433 296.311 0.483
202209 0.341 296.808 0.379
202212 0.058 296.797 0.065
202303 0.399 301.836 0.437
202306 0.541 305.109 0.586
202309 0.377 307.789 0.404
202312 0.548 306.746 0.590
202403 0.548 312.332 0.579
202406 0.323 314.175 0.339
202409 0.236 315.301 0.247
202412 0.406 315.605 0.425
202503 0.557 319.799 0.575
202506 0.341 322.561 0.349
202509 0.415 324.800 0.422
202512 0.500 324.054 0.510
202603 0.368 330.213 0.368

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$0.00 mean?
Sinphar Pharmaceutical Co (TPE:1734) has a E10 of NT$0.00 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors.
Is Sinphar Pharmaceutical Co's E10 too high?
Sinphar Pharmaceutical Co's current E10 is NT$0.00. Overall, Sinphar Pharmaceutical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinphar Pharmaceutical Co's E10 compare to VRTX and REGN?
Sinphar Pharmaceutical Co's E10 of NT$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors. Sinphar Pharmaceutical Co's current E10 is NT$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinphar Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinphar Pharmaceutical Co (TPE:1734) is currently considered Fairly Valued. The stock's GF Value™ is NT$31.46, compared to a current price of NT$31.80 — trading 1.1% above its estimated fair value. The current E10 is NT$0.00. Sinphar Pharmaceutical Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sinphar Pharmaceutical Co (TPE:1734), the current E10 is NT$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinphar Pharmaceutical Co (TPE:1734) Overvalued in 2026?

Based on GuruFocus' analysis, Sinphar Pharmaceutical Co stock appears to be overvalued. The current stock price of NT$31.80 is trading 1.1% above its estimated GF Value™ of NT$31.46. GuruFocus considers Sinphar Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TPE:1734:

  • E10: NT$0.00
  • GF Value™: NT$31.46 vs. price of NT$31.80 (1.1% above fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the TPE:1734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinphar Pharmaceutical Co Business Description

Address No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.
81GF Score

Get the complete analysis for TPE:1734

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.80
Price
NT$31.46
GF Value